Biochemical diagnosis and localization of pheochromocytoma - Can we reach a consensus?

被引:72
|
作者
Grossman, Ashley [1 ]
Pacak, Karel
Sawka, Anna
Lenders, Jacques W. M.
Harlander, Debra
Peaston, Robert T.
Reznek, Rodney
Sisson, James
Eisenhofer, Graeme
机构
[1] St Bartholomews Hosp, Dept Endocrinol, London EC1A 7BE, England
[2] NICHHD, Reprod Biol & Med Branch, NIH, Bethesda, MD 20892 USA
[3] Univ Toronto, Dept Med, Toronto, ON, Canada
[4] St Radboud Hosp, Dept Gen Internal Med, Nijmegen, Netherlands
[5] Pheochromocytoma Support Grp, Camden, NY 13316 USA
[6] Freeman Rd Hosp, Dept Clin Biochem, Newcastle Upon Tyne, Tyne & Wear, England
[7] St Bartholomews Hosp, Div Radiol, London EC1A 7BE, England
[8] Univ Michigan Hosp, Dept Radiol, Ann Arbor, MI 48109 USA
[9] NINDS, Clin Neurocardiol Sect, NIH, Bethesda, MD 20892 USA
来源
PHEOCHROMOCYTOMA | 2006年 / 1073卷
关键词
pheochromocytoma; biochemical diagnosis; metanephrines; catecholamines; localization; computed tomography; magnetic resonance imaging; MIBG; positron emission tomography;
D O I
10.1196/annals.1353.038
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Pheochromocytomas can have a highly variable presentation, making diagnosis challenging. To think of the tumor represents the crucial initial step, but establishing the diagnosis requires biochemical evidence of excessive catecholamine production and imaging studies to localize the source. Currently, however, there exist no generally agreed upon guidelines based on which tests and testing algorithms should be used to confirm and locate or exclude a suspected pheochromocytoma. Choice of biochemical tests and imaging studies instead usually depends on institutional experience. At the First International Symposium on Pheochromocytoma (ISP2005), held in Bethesda in October 2005, a panel of experts and patient representatives discussed current problems and available options for tumor diagnosis and localization and formulated recommendations, which were subsequently agreed upon by those in attendance at the meeting. This article summarizes the discussion and recommendations derived from that session.
引用
收藏
页码:332 / 347
页数:16
相关论文
共 50 条
  • [1] CAN WE REACH CONSENSUS ON CENSUS ADJUSTMENT
    BELIN, TR
    ROLPH, JE
    STATISTICAL SCIENCE, 1994, 9 (04) : 486 - 508
  • [2] DEFINING STS - CAN WE REACH CONSENSUS
    DURBIN, PT
    BULLETIN OF SCIENCE TECHNOLOGY & SOCIETY, 1991, 11 (4-5) : 187 - 190
  • [3] Bicycle helmet legislation: Can we reach a consensus?
    Robinson, D. L.
    ACCIDENT ANALYSIS AND PREVENTION, 2007, 39 (01): : 86 - 93
  • [4] CAN WE REACH CONSENSUS ON CENSUS ADJUSTMENT - COMMENT
    DIAMOND, I
    SKINNER, C
    ERICKSEN, EP
    FIENBERG, SE
    KADANE, JB
    STATISTICAL SCIENCE, 1994, 9 (04) : 508 - 537
  • [5] COTS terminology and categories: Can we reach a consensus?
    Clark, B
    Torchiano, M
    COTS BASED SOFTWARE SYSTEMS, PROCEEDINGS, 2004, 2959 : 4 - 5
  • [6] TREATMENT OF LUPUS PREGNANCY - CAN WE REACH CONSENSUS
    LOCKSHIN, MD
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1992, 10 (05) : 429 - 431
  • [7] Gestational Diabetes Mellitus: Can We Reach Consensus?
    Carol J. Homko
    Current Diabetes Reports, 2010, 10 (4) : 252 - 254
  • [8] Can we reach a consensus margin policy for Lentigo Maligna?
    Slater, J.
    Cliff, S.
    Pakzad, F.
    Ajaz, M.
    Sewell, S.
    BRITISH JOURNAL OF DERMATOLOGY, 2018, 179 : 129 - 129
  • [9] Kallmann syndrome ... can we reach an earlier diagnosis?
    Martins, Sandrina
    Ribeiro, Luis
    Cardoso, Helena
    Oliveira, Maria Joao
    Borges, Teresa
    REVISTA PORTUGUESA DE ENDOCRINOLOGIA DIABETES E METABOLISMO, 2012, 7 (02) : 18 - 22
  • [10] Biochemical diagnosis of pheochromocytoma
    Eisenhofer, G
    Lenders, JWM
    Pacak, K
    PHEOCHROMOCYTOMA: PATHOPHYSIOLOGY AND CLINICAL MANAGEMENT, 2004, 31 : 76 - 106